Melanoma

Opdivo approval expanded to include lung cancer

(HealthDay)—U.S. Food and Drug Administration approval of Opdivo (nivolumab) has been expanded to include advanced non-small cell lung cancer (NSCLC), the agency said Wednesday in a news release.

Mar 04, 2015
popularity 2 comments 0

The future of precision immunology

In his State of the Union address, President Obama announced a new precision medicine initiative to work on finding a cure for cancer and other diseases. Howard L. Kaufman, a leading immunotherapy expert ...

Jan 30, 2015
popularity 22 comments 0

MS patients cheer FDA OK of new drug

Patients facing limited options for treating their relapsing multiple sclerosis are celebrating the FDA's approval of a new aggressive drug treatment. The ruling reverses the agency's decision a year ago that the drug was ...

Dec 29, 2014
popularity 2 comments 0

Treatments show promise in metastatic melanoma

(HealthDay)—In metastatic melanoma, nivolumab improves overall and progression-free survival versus dacarbazine, and dabrafenib plus trametinib improves survival versus vemurafenib monotherapy, according ...

Nov 18, 2014
popularity 0 comments 0

Latest Spotlight News

In Alzheimer's mice, memory restored with cancer drug

Memory and as well as connections between brain cells were restored in mice with a model of Alzheimer's given an experimental cancer drug, Yale School of Medicine researchers reported in the journal Annals of ...